Predict your next investment

HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
epitomics.com

See what CB Insights has to offer

Founded Year

2001

Stage

Acquired | Acquired

Valuation

$0000 

Revenue

$0000 

About Epitomics

Epitomics is a maker and commercial supplier of monoclonal antibodies for human therapeutics development. The company offers reagents, diagnostics, and contract research to leading scientific researchers.In March 2012, Epitomics was acquired by Abcam. The valuation of Epitomics was $170 million.

Epitomics Headquarter Location

863 Mitten Road Suite 103

Burlingame, California, 94010,

United States

650-583-6688

Latest Epitomics News

Antibody Production Market Trends to 2025 Merck KGaA, General Electric Company, Eppendorf AG, Epitomics – an Abcam Company, Roche Molecular Systems, Inc., Enzo Life Sciences, Inc., Proteintech Group, Bio-Rad Laboratories, Inc., and Novus Biologicals

Nov 19, 2018

The growth of the antibody production market is driven by the key factors such as increasing funding for the research and development for biopharmaceutical companies. In addition, the regulatory bodies also approve therapeutic antibodies for commercialization. The increase in the infectious diseases are generating opportunities for the antibody producing companies to produce more antibodies for the different antigens. Antibody is also known as immunoglobulin, which is Y-shaped protein that is produced by the immune system to prevent invaders from harming the body. If it is found then the immune system starts producing antibody, which is an invivo process, however the antibody can be created invitro. The antibody production market comprises products that are required during the different stages of bioprocessing of antibodies, such as upstream processing, downstream processing, and filtration. Get PDf Sample @  https://www.theinsightpartners.com/sample/TIPHE100001114   The growth of the antibody production market is driven by the key factors such as increasing funding for the research and development for biopharmaceutical companies. In addition, the regulatory bodies also approve therapeutic antibodies for commercialization. The increase in the infectious diseases are generating opportunities for the antibody producing companies to produce more antibodies for the different antigens. The “Global Antibody Production Market Analysis to 2025” is a specialized and in-depth study of the antibody production industry with a focus on the global market trend. The report aims to provide an overview of global antibody production market with detailed market segmentation by type, device, end user, and geography. The global antibody production market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market. The antibody production market is segmented based on type as monoclonal antibody and polyclonal antibody. The antibody production market is segmented on the basis of devices as bioreactors, chromatography and consumables. The end user segment is classified as biopharmaceutical/ pharmaceutical companies, research & academic institutes, diagnostic laboratories. The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global antibody production market based on instrument, reagent, and software & services. It also provides market size and forecast till 2025 for overall antibody production market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region. North America is expected to be the largest market for the antibody production in the global scenario. Asia Pacific is the fastest growing market for the antibody production market as various technological developments in the healthcare industry and rising research activities. In addition, the company owing patent against antibody creates an opportunity for other company to claim the intellectual property right for similar product. About Us The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost. Contact us:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Epitomics Patents

Epitomics has filed 25 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/11/2016

3/2/2021

Clusters of differentiation, Immunology, Immune system, Monoclonal antibodies, Molecular biology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

3/11/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

3/2/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Clusters of differentiation, Immunology, Immune system, Monoclonal antibodies, Molecular biology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.